Salivary procalcitonin and periodontitis in diabetes

Journal of Dental Research

Volumn 87, Issue 7, 2008, Pages 630-634

  Bassim, C W ^a,b   Redman, R S ^a   DeNucci, D J ^a,b   Becker, K L ^a,c   Nylen, E S ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Diabetes; Periodontitis; Procalcitonin; Saliva

Indexed keywords

BIOLOGICAL MARKER; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ARTICLE; CASE CONTROL STUDY; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; PERIODONTICS; PERIODONTITIS; REFERENCE VALUE; SALIVA; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CALCITONIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; PROTEIN PRECURSORS; REFERENCE VALUES; SALIVA; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 47649085202     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910808700707     Document Type: Article

References (37)

1. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr (2004). Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512-1525.
2. Bellamy JL, Cady RK, Durham PL (2006). Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 46:24-33.
3. Choi DH, Moon IS, Choi BK, Paik JW, Kim YS, Choi SH, et al. (2004). Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res 39:20-26.
4. Collin HL, Sorsa T, Meurman JH, Niskanen L, Salo T, Ronka H, et al. (2000). Salivary matrix melalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. J Periodontal Res 35:259-265.
5. Dandona P, Nix D, Wilson M, Aljada A, Love J, Assicot M, et al. (1994). Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605-1608.
6. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H (2004). The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 75:06-115.
7. Forsberg JA, Elster EA, Anderson RC, Nylen E, Brown TS, Rose MW, et al. (2008). Correlation of procalcitonin and cytokine expression with wound dehiscence in wartime extremity injuries. J Bone Joint Surg Am 90:580-588.
8. Janket SJ, Wightman A, Baird A, Van Dyke T, Jones JA (2005). Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 84:1154-1159.
9. Kapas S, Pahal K, Cruchley AT, Hagi-Pavli E, Hinson JP (2004). Expression of adrenomedullin and its receptors in human salivary tissue. J Dent Res 83:333-337.
10. Kaufman E, Lamster IB (2002). The diagnostic applications of saliva: a review. Crit Rev Oral Biol Med 13:197-212.
11. Kumar MS, Vansi G, Sripriya R, Sehgal PK (2006). Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus. J Periodontol 77:1803-1808. (AQ)
12. Löe H (1993). Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care 16:329-334.
13. Lopez J, Martinez A (2002). Cell and molecular biology of the multifunctional peptide adrenomedullin. Int Rev Cytol 221:1-92.
14. Lundy FT, Linden GJ (2004). Neuropeptides and neurogenic mechanisms in oral and periodontal inflammation. Crit Rev Oral Biol Med 15:82-98.
15. Marutsuka K, Nawa Y, Asada Y, Hara S, Kitamura K, Eto T, et al. (2001). Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Exp Physiol 86:543-545.
16. Mealey BL, Oates TW (2006). Diabetes mellitus and periodontal disease. J Periodontol 77:1289-1303.
17. Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV (2006). Salivary biomarkers of existing periodontal disease: a cross sectional study. J Am Dent Assoc 137:322-329.
18. Müller B, White JC, Nylén ES, Snider RH Jr, Becker KL, Habener JF (2001). Ubiquitous expression of the calcitonin-1 gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86:396-404.
19. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL (1998). Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26:1001-1006.
20. Preas HL, Nylen ES, Snider RH Jr, Becker KL, White JC, Agosti JM, et al. (2001). Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 184:373-376.
21. Quagliarello V, Han I, Ginter S, Van Ness P, Allore H, Tinette M (2005). Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 40:1-6.
22. R Development Core Team (2006). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
23. Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, et al. (2005). Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28:27-32.
24. Scannapieco FA, Bush RB, Paju S (2003a). Associations between periodontal disease and the risk for atherosclerosis, cardiovascular disease, and stroke. A systemic review. Ann Periodontol 8:38-53.
25. Scannapieco FA, Bush RB, Paju S (2003b). Periodontal disease as a risk factor for adverse pregnancy outcomes. Ann Periodontol 8:70-78.(AQ)
26. Shoelson SE, Lee J, Goldfine AB (2006). Inflammation and insulin resistance. J Clin Invest 116:1793-1801.
27. Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ, et al. (2007). Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30:306-311.
28. Slavkin H, Baum B (2000). Relationship of dental and oral pathology to systemic illness. J Am Med Assoc 284:1215-1217.
29. Snider RH Jr, Nylen ES, Becker KL (1997). Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 45:552-560.
30. Streckfus C, Bigler L (2005). The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv Dent Res 18:17-24.
31. Syrenicz A, Garanty-Bogacka B, Syrenicz M, Bebala A, Walczak M (2006). Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neurol Endocrinol Lett 27:453-458.
32. Tabak LA (2001). A revolution in biomedical assessment: the development of salivary diagnostics. J Dent Educ 65:1335-1339.
33. Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, et al. (2002). Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 51:743-749.
34. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al (2007). Treatment of periodontitis and endothelial function. N Engl J Med 356:911-920.
35. Wennström JL, Tomasi C, Bertelle A, Dellasega E (2005). Full-mouth ultrasonic debridement versus quadrant scaling and root planing as an initial approach in the treatment of chronic periodontitis. J Clin Periodontol 32:851-859.
36. Whang KT, Steinwald PM, White JC, Nylen ES, Snider RH Jr, Simon GL, et al. (1998). Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 83:3296-3301.
37. Wiebe CB, Putnins EE (2000). The periodontal disease classification system of the American Academy of Periodontology: an update. J Can Dent Assoc 66:594-597.